SubscribeLogin
Published

William Blair Reaffirms “Market Perform” Rating for FibroGen (NASDAQ:FGEN)

Summary by reporter.am
William Blair reiterated their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report issued on Wednesday,RTT News reports. Separately, StockNews.com began coverage on shares of FibroGen in a research report on Wednesday, November 6th. They set a “hold” rating on the stock. Check Out Our Latest Stock Analysis on FGEN […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Bill BlairBill Blair
Stock MarketsStock Markets
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal